Get Connected:


About AJPB


To provide pharmacy and formulary decision makers with the information they need to improve the efficiency and health outcomes in managing pharmaceutical care.

Editorial Overview

The American Journal of Pharmacy Benefits (AJPB) publishes peer-reviewed research that examines the impact of formulary management strategies on the utilization, cost, and quality of pharmacy services. The Journal presents case studies, research, and evidence-based tools to help decision makers develop clinical strategies to manage pharmacy benefits for large populations. Areas of particular interest include utilization management strategies (ie, prior authorization, step therapy, generic substitution, etc), outcomes research on Medicare Part D, formulary development and implementation strategies, research on adherence and compliance, cost sharing strategies (ie, copays, coinsurance, CDHPs, HDHPs, etc), cost utility analyses, economic burden of disease, and comparative effectiveness analysis of drug therapies.

All original articles are subjected to rigorous peer review. Manuscripts are also evaluated to determine the real world relevance of the information they contain. In addition to original research, the journal publishes review articles, commentaries, brief reports, editorials, or letters to the editor.

The American Journal of Pharmacy Benefits was founded in 2009 as a sister publication to The American Journal of Managed Care. The Journal is indexed in both EMBASE and Cumulative Index to Nursing and Allied Health Literature (CINAHL), and circulates to approximately 20,000 individuals with important decision-making responsibilities affecting the inclusion and tier placement of drugs on formularies. As the official publication of The Pharmacy & Therapeutics Society, the Journal is distributed to the Society’s 5000 members, as well as medical directors, pharmacy directors, corporate benefits managers, and other healthcare professionals across these 6 market segments: 1) HMO/PPO/IHOs; 2) hospitals; 3) long-term care; 4) PBMs; 5) VA/gov’t; and 6) employers.

The American Journal of Pharmacy Benefits (ISSN 1945-4481 [print]; ISSN 2164-2494 [online]) is published bimonthly by Managed Care & Healthcare Communications, LLC, 2 Clarke Drive, Suite 100, Cranbury, NJ 08512. Copyright ? 2010 by Managed Care & Healthcare Communications, LLC.

About the Editors

Jan E. Berger, MD, MJ

Dr. Berger founded Health Intelligence Partners in 2008 as a healthcare consultancy that blends 25 years of business and clinical experience to bring value to her clients.

As former Senior Vice President and Chief Clinical Officer for CVS Caremark (1999-2008), Dr. Berger was a member of the executive team for the organization. Over a 9-year period this team led the organization through 3 mergers and acquisitions, which resulted in an $80 billion dollar, Fortune 24, healthcare organization with more than 190,000 employees throughout the United States. She was responsible for policy and strategy for all clinical aspects of the organization, including pharmacy benefit services, specialty pharmacy, Medicare Part D, disease and health management, and health information technology. Dr. Berger was also responsible for taking a leadership role in representing CVS Caremark at a variety of national healthcare policy forums during her tenure. Prior to coming to CVS Caremark, Dr. Berger had 15 years experience in healthcare administration within the health plan and academic arenas.

Editor-in-Chief of The American Journal of Pharmacy Benefits and on the editorial boards several other healthcare journals, Dr. Berger is considered a national healthcare thought leader. Dr. Berger speaks and writes on a broad range of healthcare issues. She also serves on numerous healthcare boards and committees and has published more than 100 articles and publications.

Dr. Berger is a "black belt" in Six Sigma, designating her as a team leader responsible for implementing process improvement projects within business to increase customer satisfaction and business productivity.

Dr. Berger holds both a Doctor of Medicine degree and a Masters degree in Jurisprudence from Loyola University in Chicago and a Certificate in Healthcare Business Administration from the University of South Florida. She is also an assistant professor at Northwestern University School of Medicine in Evanston, Illinois.

Editorial Board Members


Jan E. Berger, MD, MJ
President & CEO • Health Intelligence Partners • Northbrook, IL

Kimberly A. Bergstrom, PharmD
Chief Clinical Officer • McKesson Corporation • San Rafael, CA

J. Lyle Bootman, PhD, ScD
Dean, College of Pharmacy • University of Arizona • Tucson, AZ

William B. Bunn, III, MD, JD, MPH
Vice President of Health, Safety, Security, & Productivity • Navistar International • Warrenville, IL

Jason G. Cooper
Vice President, Business Analytics • Wellmark • Des Moines, IA

Mitchell P. DeKoven, MHSA
Principal, Health Economics & Outcomes Research • IMS Health • Oak Hill, VA

Joseph Doyle, RPh, MBA
Director, Evidence Based Medicine?Employer Research • Novartis • East Hanover, NJ

Gail R. Gratz-Levenson, RPh
Director, Health Management Services • National Rural Electric Cooperative Association • Arlington, VA

Laura Long, MD, MPH
Vice President, Clinical Innovation • BlueCross BlueShield of South Carolina • Columbia, SC

Rose Maljanian, RN, MBA
Chairman & CEO • HealthCAWS, Inc. • Farmington, CT

Darlene M. Mednick, PhD, RPh, MBA
Vice President, Pharmacy Services • Gorman Health Group • New York, NY

Thomas J. Morrow, MD
Director, Value-Based Health • Genentech • Alpharetta, GA

Kavita Nair, PhD
Department of Clinical Pharmacy • University of Colorado • Denver, CO

Cyndy Nayer, MA
CEO • Center of Health Engagement • Naples, FL

Edmund J. Pezalla, MD, MPH
National Medical Director • Aetna Pharmacy Management • Hartford, CT

Richard G. Popiel, MD, MBA
Executive Vice President, Health Care Services, Chief Medical Officer • Regence • Portland, OR

Helen Sherman, PharmD
Chief Pharmacy Officer, Pharmacy Services • RegenceRx • Portland, OR

William H. Shrank, MD
Division of Pharmacoepidemiology • Harvard Medical School • Boston, MA

Julie Slezak, MS
Chief Analytics Officer • CareCore National • Bluffton, SC

Yvonne Southwell, RPh
Vice President, Clinical Affairs • CVS/Caremark • Northbrook, IL

Michael L. Taylor, MD
Chief Medical Officer • Truven Health Analytics • Ann Arbor, MI

Where We're Indexed

Cumulative Index to Nursing and Allied Health Literature

EMBASE/Excerpta Medica